Intensive lifestyle changes for reversal of coronary heart disease

被引:957
作者
Ornish, D
Scherwitz, LW
Billings, JH
Gould, KL
Merritt, TA
Sparler, S
Armstrong, WT
Ports, TA
Kirkeeide, RL
Hogeboom, C
Brand, RJ
机构
[1] Res Inst Prevent Med, Sausalito, CA 94965 USA
[2] Calif Pacific Med Ctr, Dept Med, San Francisco, CA USA
[3] Calif Pacific Med Ctr, Div Cardiol, San Francisco, CA USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[5] Univ Calif San Francisco, Cardiovasc Res Inst, Cardiac Catheterizat Lab, San Francisco, CA USA
[6] Univ Calif San Francisco, Sch Med, Div Biostat, San Francisco, CA USA
[7] Univ Texas, Sch Med, Div Cardiol, Houston, TX USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1998年 / 280卷 / 23期
关键词
D O I
10.1001/jama.280.23.2001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context.-The Lifestyle Heart Trial demonstrated that intensive lifestyle changes may lead to regression of coronary atherosclerosis after 1 year. Objectives.-To determine the feasibility of patients to sustain intensive lifestyle changes for a total of 5 years and the effects of these lifestyle changes (without lipid-lowering drugs) on coronary heart disease. Design.-Randomized controlled trial conducted from 1986 to 1992 using a randomized invitational design. Patients.-Forty-eight patients with moderate to severe coronary heart disease were randomized to an intensive lifestyle change group or to a usual-care control group, and 35 completed the 5-year follow-up quantitative coronary arteriography, Setting.-Two tertiary care university medical centers. Intervention.-Intensive lifestyle changes (10% fat whole foods vegetarian diet, aerobic exercise, stress management training, smoking cessation, group psychosocial support) for 5 years. Main Outcome Measures.-Adherence to intensive lifestyle changes, changes in coronary artery percent diameter stenosis, and cardiac events. Results.-Experimental group patients (20 [71%] of 28 patients completed Ei-year follow-up) made and maintained comprehensive lifestyle changes for 5 years, whereas control group patients (15 [75%] of 20 patients completed 5-year follow-up) made more moderate changes. In the experimental group, the average percent diameter stenosis at baseline decreased 1.75 absolute percentage points after 1 year (a 4.5% relative improvement) and by 3.1 absolute percentage points after 5 years (a 7.9% relative improvement). In contrast, the average percent diameter stenosis in the control group increased by 2.3 percentage points after 1 year (a 5.4% relative worsening) and by 11.8 percentage points after 5 years (a 27.7% relative worsening) (P=.001 between groups. Twenty-five cardiac events occurred in 28 experimental group patients vs 45 events in 20 control group patients during the 5-year follow-up (risk ratio for any event for the control group, 2.47 [95% confidence interval, 1.48-4.20]). Conclusions.-More regression of coronary atherosclerosis occurred after 5 years than after 1 year in the experimental group. In contrast, in the control group, coronary atherosclerosis continued to progress and more than twice as many cardiac events occurred.
引用
收藏
页码:2001 / 2007
页数:7
相关论文
共 33 条
[1]  
American College of Sports Medicine, 1986, GUID EX TEST PRESCR
[2]  
[Anonymous], 1992, P229 SAS I INC
[3]   Persistence of use of lipid-lowering medications - A cross-national study [J].
Avorn, J ;
Monette, J ;
Lacour, A ;
Bohn, RL ;
Monane, M ;
Mogun, H ;
LeLorier, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1458-1462
[4]  
BILLINGS JH, 1996, HEART MIND PRACTICE, P233
[5]   A LOW-FAT DIET DECREASES HIGH-DENSITY LIPOPROTEIN (HDL) CHOLESTEROL LEVELS BY DECREASING HDL APOLIPOPROTEIN TRANSPORT RATES [J].
BRINTON, EA ;
EISENBERG, S ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (01) :144-151
[6]   REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].
BROWN, G ;
ALBERS, JJ ;
FISHER, LD ;
SCHAEFER, SM ;
LIN, JT ;
KAPLAN, C ;
ZHAO, XQ ;
BISSON, BD ;
FITZPATRICK, VF ;
DODGE, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298
[7]  
Connor WE, 1997, NEW ENGL J MED, V337, P562
[8]  
Connor WE, 1997, NEW ENGL J MED, V337, P566
[9]  
ESSELSTYN CB, 1995, J FAM PRACTICE, V41, P560
[10]   CHANGES IN MYOCARDIAL PERFUSION ABNORMALITIES BY POSITRON EMISSION TOMOGRAPHY AFTER LONG-TERM, INTENSE RISK FACTOR MODIFICATION [J].
GOULD, KL ;
ORNISH, D ;
SCHERWITZ, L ;
BROWN, S ;
EDENS, RP ;
HESS, MJ ;
MULLANI, N ;
BOLOMEY, L ;
DOBBS, F ;
ARMSTRONG, WT ;
MERRITT, T ;
PORTS, T ;
SPARLER, S ;
BILLINGS, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (11) :894-901